Compare BWB & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWB | BWAY |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | Israel |
| Employees | 337 | 129 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 557.7M | 578.5M |
| IPO Year | N/A | N/A |
| Metric | BWB | BWAY |
|---|---|---|
| Price | $21.10 | $15.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $21.67 | $13.25 |
| AVG Volume (30 Days) | ★ 247.7K | 88.4K |
| Earning Date | 04-21-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.57 | $309.69 |
| Revenue Next Year | $12.35 | $26.21 |
| P/E Ratio | ★ $12.97 | $81.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.90 | $11.35 |
| 52 Week High | $21.23 | $26.63 |
| Indicator | BWB | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 71.36 | 58.16 |
| Support Level | $16.33 | $14.31 |
| Resistance Level | N/A | $16.35 |
| Average True Range (ATR) | 0.49 | 0.62 |
| MACD | 0.12 | 0.14 |
| Stochastic Oscillator | 91.88 | 88.95 |
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.